Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Variability in the burden of disease estimates with or without age weighting and discounting: a methodological study.

Egunsola O, Raubenheimer J, Buckley N.

BMJ Open. 2019 Aug 18;9(8):e027825. doi: 10.1136/bmjopen-2018-027825.

2.

Clinical trials in Asia: A World Health Organization database study.

Ali S, Egunsola O, Babar ZUD, Hasan SS.

Perspect Clin Res. 2019 Jul-Sep;10(3):121-124. doi: 10.4103/picr.PICR_109_18.

3.

Systematic Review of the Efficacy and Safety of Gabapentin and Pregabalin for Pain in Children and Adolescents.

Egunsola O, Wylie CE, Chitty KM, Buckley NA.

Anesth Analg. 2019 Apr;128(4):811-819. doi: 10.1213/ANE.0000000000003936.

PMID:
30451725
4.

Adverse drug reaction reporting in a large tertiary hospital in Saudi Arabia: results of an incentive strategy.

Ali S, Egunsola O, Al-Dossari DS, Al-Zaagi IA.

Ther Adv Drug Saf. 2018 Aug 11;9(10):585-590. doi: 10.1177/2042098618790209. eCollection 2018 Oct.

5.

Protocol for a prospective observational study of adverse drug reactions of anti-epileptic drugs in children in the UK.

Egunsola O, Sammons HM, Ojha S, Whitehouse W, Anderson M, Hawcutt D, Choonara I.

BMJ Paediatr Open. 2017 Aug 4;1(1):e000116. doi: 10.1136/bmjpo-2017-000116. eCollection 2017.

6.

Anti-epileptic drug utilisation in paediatrics: a systematic review.

Egunsola O, Choonara I, Sammons HM.

BMJ Paediatr Open. 2017 Aug 11;1(1):e000088. doi: 10.1136/bmjpo-2017-000088. eCollection 2017.

7.

Retrospective review of paediatric case reports of Stevens-Johnson syndrome and toxic epidermal necrolysis with lamotrigine from an international pharmacovigilance database.

Egunsola O, Star K, Juhlin K, Kardaun SH, Choonara I, Sammons HM.

BMJ Paediatr Open. 2017 Aug 4;1(1):e000039. doi: 10.1136/bmjpo-2017-000039. eCollection 2017.

8.

Safety of antiepileptic drugs in children and young people: A prospective cohort study.

Egunsola O, Choonara I, Sammons HM, Whitehouse WP.

Seizure. 2018 Mar;56:20-25. doi: 10.1016/j.seizure.2018.01.018. Epub 2018 Feb 2.

9.

Discontinuities and disruptions in drug dosage guidelines for the paediatric population.

Chitty KM, Chan B, Pulanco CL, Luu S, Egunsola O, Buckley NA.

Br J Clin Pharmacol. 2018 May;84(5):1029-1037. doi: 10.1111/bcp.13511. Epub 2018 Feb 21.

10.

Safety of Levetiracetam in Paediatrics: A Systematic Review.

Egunsola O, Choonara I, Sammons HM.

PLoS One. 2016 Mar 1;11(3):e0149686. doi: 10.1371/journal.pone.0149686. eCollection 2016. Review.

11.

Monotherapy or polytherapy for childhood epilepsies?

Egunsola O, Sammons HM, Whitehouse WP.

Arch Dis Child. 2016 Apr;101(4):356-8. doi: 10.1136/archdischild-2015-309466. Epub 2015 Dec 15. No abstract available.

PMID:
26672103
12.

Use and safety of azithromycin in neonates: a systematic review.

Smith C, Egunsola O, Choonara I, Kotecha S, Jacqz-Aigrain E, Sammons H.

BMJ Open. 2015 Dec 9;5(12):e008194. doi: 10.1136/bmjopen-2015-008194. Review.

13.

Safety of lamotrigine in paediatrics: a systematic review.

Egunsola O, Choonara I, Sammons HM.

BMJ Open. 2015 Jun 12;5(6):e007711. doi: 10.1136/bmjopen-2015-007711. Review.

14.

A prospective study of adverse drug reactions to antiepileptic drugs in children.

Anderson M, Egunsola O, Cherrill J, Millward C, Fakis A, Choonara I.

BMJ Open. 2015 Jun 1;5(6):e008298. doi: 10.1136/bmjopen-2015-008298.

15.

Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic review.

Egunsola O, Oshikoya KA.

Malar J. 2013 Nov 1;12:385. doi: 10.1186/1475-2875-12-385. Review.

16.

Is tenofovir/emtricitabine teratogenic?

Jibril M, Egunsola O.

Ther Adv Drug Saf. 2013 Jun;4(3):115-7. doi: 10.1177/2042098613485276.

17.

Safety of fluconazole in paediatrics: a systematic review.

Egunsola O, Adefurin A, Fakis A, Jacqz-Aigrain E, Choonara I, Sammons H.

Eur J Clin Pharmacol. 2013 Jun;69(6):1211-21. doi: 10.1007/s00228-012-1468-2. Epub 2013 Jan 17. Review.

Supplemental Content

Loading ...
Support Center